Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00005195
Status:
COMPLETED
Last Update Posted:
2016-03-16
First Post:
2000-05-25
Brief Title:
Catheter Ablation Registry
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Heart Lung and Blood Institute NHLBI
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2002-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess factors associated with safety and efficacy of catheter ablation using direct current or radiofrequency energy for the management of patients with drug andor pacemaker resistant cardiac arrhythmias
Detailed Description:
BACKGROUND
Cardiac tachyarrhythmias that are refractory to either conventional or experimental antiarrhythmic therapy antitachycardia pacemakers or both may result in serious symptoms or death Catheter ablation has been developed as a nonpharmacologic closed-chest alternative for the management of these patients The technique was first applied to man in 1981 and reported by both Scheinman et al and Gallagher et al in 1982 Hartzler reported the first catheter ablation procedure for the treatment of ventricular tachycardia in 1983 In that same year Weber reported the first use of catheter ablation of an accessory atrioventricular pathway The standard method of energy delivery for closed-chest catheter ablation attempts involved direct current delivered using a defibrillator but beginning in 1985 radiofrequency energy was employed in man This promised to revolutionize the field of catheter ablation because it offered the hope of more precise destruction of tissue avoided the need for general anesthesia and significantly lowered complication rates since it did not involve the levels of energy used in direct current attempts
The Catheter Ablation Registry CAR evolved from a pilot study the Percutaneous Cardiac Mapping and Ablation Registry PCMAR formed in 1983 There were scientific limitations in this voluntary registry Further prospective studies were needed to better define this procedure and a multicenter international prospective cohort study was designed to allow a rapid assessment of ablations dangers and potential usefulness Results from the study were used to guide physicians as to which patients would and would not benefit from these new procedures
DESIGN NARRATIVE
Data were collected prospectively from sixteen clinical centers in the United States and Europe on attempted catheter ablation of the atrioventricular junction accessory atrioventricular pathways and ventricular tachycardia Each of the three ablation techniques was studied as a separate subset and the two methods of energy delivery direct current or radiofrequency energy were compared within each subset A standardized protocol was used for direct current ablation and the results of a variety of protocols for the other two procedures and for radiofrequency energy were observed Patients were evaluated quarterly in the first post-procedure year and biannually for the subsequent duration of the study Statistical analyses were performed to determine the distribution of specific patient characteristics such as age sex clinical status underlying heart disease and a variety of procedural categories including energy level mapping data and catheter position A determination was made of the frequency of successful outcomes including cessation of arrhythmias production of third degree atrioventricular block and disappearance of symptoms and of adverse effects including procedure-related complications and death
The study completion date listed in this record was obtained from the End Date entered in the Protocol Registration and Results System PRS record
Cardiac tachyarrhythmias that are refractory to either conventional or experimental antiarrhythmic therapy antitachycardia pacemakers or both may result in serious symptoms or death Catheter ablation has been developed as a nonpharmacologic closed-chest alternative for the management of these patients The technique was first applied to man in 1981 and reported by both Scheinman et al and Gallagher et al in 1982 Hartzler reported the first catheter ablation procedure for the treatment of ventricular tachycardia in 1983 In that same year Weber reported the first use of catheter ablation of an accessory atrioventricular pathway The standard method of energy delivery for closed-chest catheter ablation attempts involved direct current delivered using a defibrillator but beginning in 1985 radiofrequency energy was employed in man This promised to revolutionize the field of catheter ablation because it offered the hope of more precise destruction of tissue avoided the need for general anesthesia and significantly lowered complication rates since it did not involve the levels of energy used in direct current attempts
The Catheter Ablation Registry CAR evolved from a pilot study the Percutaneous Cardiac Mapping and Ablation Registry PCMAR formed in 1983 There were scientific limitations in this voluntary registry Further prospective studies were needed to better define this procedure and a multicenter international prospective cohort study was designed to allow a rapid assessment of ablations dangers and potential usefulness Results from the study were used to guide physicians as to which patients would and would not benefit from these new procedures
DESIGN NARRATIVE
Data were collected prospectively from sixteen clinical centers in the United States and Europe on attempted catheter ablation of the atrioventricular junction accessory atrioventricular pathways and ventricular tachycardia Each of the three ablation techniques was studied as a separate subset and the two methods of energy delivery direct current or radiofrequency energy were compared within each subset A standardized protocol was used for direct current ablation and the results of a variety of protocols for the other two procedures and for radiofrequency energy were observed Patients were evaluated quarterly in the first post-procedure year and biannually for the subsequent duration of the study Statistical analyses were performed to determine the distribution of specific patient characteristics such as age sex clinical status underlying heart disease and a variety of procedural categories including energy level mapping data and catheter position A determination was made of the frequency of successful outcomes including cessation of arrhythmias production of third degree atrioventricular block and disappearance of symptoms and of adverse effects including procedure-related complications and death
The study completion date listed in this record was obtained from the End Date entered in the Protocol Registration and Results System PRS record
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01HL035077 | NIH | None | httpsreporternihgovquickSearchR01HL035077 |